ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,085Medicare Part D Prescriptions Filled, Including Refills

Rank: 451 out of 6645

$1.12M Total Retail Price of All Prescriptions

Rank: 246 out of 6645

601 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 601 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 11,688 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 792 715 1 1
LISINOPRIL 533 476 2 3
OMEPRAZOLE 429 379 3 6
AMLODIPINE BESYLATE 422 388 4 2
METFORMIN HCL ER 340 259 5 89
LOSARTAN POTASSIUM 338 313 6 12
CARVEDILOL 337 308 7 25
TAMSULOSIN HCL 298 297 8 22
ALENDRONATE SODIUM 247 243 9 14
PRAVASTATIN SODIUM 228 227 10 20
DIOVAN 216 212 11 19
LEVOTHYROXINE SODIUM 208 189 12 4
ATORVASTATIN CALCIUM 200 170 13 10
ACTOS 196 178 14 71
SPIRONOLACTONE 195 185 15 85
FUROSEMIDE 193 171 16 11
METOPROLOL SUCCINATE 191 172 17 24
ACTOPLUS MET 173 170 18 275
ZOLPIDEM TARTRATE 152 126 19 17
ALLOPURINOL 141 130 20 31
BENAZEPRIL HCL 140 122 21 21
HYDROCODONE-ACETAMINOPHEN 137 109 S3 22 5
AVODART 135 135 23 99
LOVASTATIN 133 130 24 15
HYDROCHLOROTHIAZIDE 129 101 25 9
FLUTICASONE PROPIONATE 128 114 26 26
IBUPROFEN 128 93 26 42
JANUMET 124 123 28 132
FINASTERIDE 118 118 29 73
ADVAIR DISKUS 114 114 30 45
PEN NEEDLE 113 81 31 159
CRESTOR 106 106 32 34
NIASPAN 102 80 33 164
METFORMIN HCL 98 79 34 7
LIPITOR 98 88 34 69
CLOPIDOGREL 93 91 36 36
FLUOXETINE HCL 87 73 37 63
PIOGLITAZONE HCL 83 77 R 38 184
PLAVIX 83 80 38 49
SPIRIVA 80 80 40 65
LOSARTAN-HYDROCHLOROTHIAZIDE 79 71 41 62
PANTOPRAZOLE SODIUM 77 77 42 29
LEVEMIR FLEXPEN 76 67 43 237
EVISTA 76 76 43 90
NAMENDA 75 75 45 41
JANUVIA 74 60 46 38
AMLODIPINE BESYLATE-BENAZEPRIL 74 70 46 97
TRIAMCINOLONE ACETONIDE 72 63 48 55
MELOXICAM 71 69 49 46
LIDODERM 71 71 49 53
ZETIA 68 68 51 87
DIOVAN HCT 67 61 52 64
CELEBREX 64 64 53 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 53 54 37
RANITIDINE HCL 61 52 55 51
BYSTOLIC 60 60 56 110
GLIMEPIRIDE 59 36 57 47
AZITHROMYCIN 58 52 58 44
EXELON 56 56 59 149
CITALOPRAM HBR 53 34 60 35
CARISOPRODOL 50 18 R 61 94
EXFORGE 50 50 61 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.